Search - tctmd.com

Displaying 1 - 20 of 323

Sort: Relevancy | Date

Presentation THT 2026

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

Presenter: Sheldon E. Litwin

March 04, 2026

Presentation THT 2026

Advances in Afib Ablation Strategies: What Does the HF Doctor Need To Know?

Presenter: Hirad Yarmohammadi

March 03, 2026

Presentation THT 2026

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Presenter: Andrea Russo

March 03, 2026

Presentation THT 2026

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

Presenter: Parag Goyal

March 03, 2026

Presentation THT Abstracts 2026

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Presenter: Jaclyn Hayma

March 02, 2026

Presentation THT Abstracts 2026

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

Presenter: Nishanth Katukuri

March 02, 2026

Presentation TCT 2025

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

Presenter: Yiyuan Huang

October 28, 2025

Presentation TCT 2025

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

Presenter: Xiaochun Zhang

October 28, 2025

Presentation TCT 2025

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

Presenter: Kuseme Udoh

October 28, 2025

Presentation TCT 2025

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 28, 2025

Presentation TCT 2025

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

Presenter: Muhammad Zahid

October 28, 2025

Presentation TCT 2025

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

Presenter: Thomas E. Waggoner

October 28, 2025

Presentation TCT 2025

TCT 51: TEMPULSE registry: Temporary Pacing Utility and Safety Evaluation

Presenter: Tomasz Skowerski

October 28, 2025

Presentation TCT 2025

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

Presenter: Jorrian Abadeer

October 28, 2025

Presentation TCT 2025

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Presenter: Michael Graf

October 28, 2025

Presentation TCT 2025

Same Setting Hybrid Procedures: Pulse Field Ablation and Left Atrial Appendage Closure

Presenter: Shephal K. Doshi

October 28, 2025

Presentation TCT 2025

TCT 1862: Pericardial Tamponade Caused by Rotational Atherectomy Ablation Grinding Through a Barrier Stent Protruding From the Diagonal Artery: A Case Report

Presenter: Minglian Gong

October 28, 2025

Presentation TCT 2025

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

Presenter: Devi G. Nair

October 28, 2025

Presentation TCT 2025

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

Presenter: Chao Gao

October 28, 2025

Presentation TCT 2025

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Presenter: Devi G. Nair

October 27, 2025

Advertisement

Serial Echocardiography After Greater Splanchnic Nerve Ablation In Hfpef Demonstrates Reductions In LV Filling Pressures In Clinical Responders But Not In Nonresponders: 12 Month Follow Up In The REBALANCE-HF Trial

Advances in Afib Ablation Strategies: What Does the HF Doctor Need To Know?

Managing Persistent Atrial Fibrillation in HF: Medications vs AV Node Ablation/Pacing vs AF Ablation

Splanchnic Nerve Ablation for Treatment of HF Across the Spectrum of LV EFs

CARDIAC RECOVERY AFTER ABLATION FOR ATRIAL FIBRILLATION

Risk of Recurrence After Atrial Fibrillation Catheter Ablation in Heart Failure with Preserved Vs Reduced Ejection Fraction

Trans-Femoral Intramyocardial Septal Radiofrequency Ablation (tf-PIMSRA) in Patients with Symptomatic HOCM: Technology Demonstration and Results of the PRIMO Study

TCT 1293: New perspectives on significant tricuspid regurgitation in patients with atrial fibrillation: left ventricular diastolic dysfunction

TCT 49: Bone Morphogenetic Protein 10 (BMP-10) as a Biomarker of Post-Ablation Atrial Fibrillation

TCT 48: Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 50: Regional and Temporal Trends in Mortality Among Older Adults With Atrial Fibrillation and Cardiac or Vascular Device Complications in the U.S. (1999–2023), With ARIMA Forecasting

TCT 732: Peri-device Leak and Clinical Outcomes After LAAC Using a Fluoropolymer Coated Device in Patients with Paroxysmal vs. Persistent Atrial Fibrillation: HEAL-LAA Post Approval Study Sub-analysis

TCT 51: TEMPULSE registry: Temporary Pacing Utility and Safety Evaluation

TCT 567: Response of Pulmonary Hypertension in Hypertrophic Obstructive Cardiomyopathy Patients Treated with Alcohol Septal Ablation

TCT 565: Survival Outcomes in Patients With and Without Devices who Undergo Alcohol Septal Ablation for HOCM

Same Setting Hybrid Procedures: Pulse Field Ablation and Left Atrial Appendage Closure

TCT 1862: Pericardial Tamponade Caused by Rotational Atherectomy Ablation Grinding Through a Barrier Stent Protruding From the Diagonal Artery: A Case Report

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation

TCT 734: Three-year clinical outcomes of left atrial appendage occlusion with or without ablation: insight from the RECORD study

TCT 711: Outcomes of Left Atrial Appendage Closure vs. Oral Anticoagulation Following Catheter Ablation in Older and Younger Patients: A Sub-analysis of the OPTION Clinical Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content